PSY51 EFFECTIVENESS OF FDA'S NEW OVER-THE-COUNTER ACETAMINOPHEN LABEL WARNING REQUIREMENTS IN IMPROVING CONSUMER RISK PERCEPTION OF LIVER DAMAGE

✍ Scribed by R.K. Goyal; S.S. Rajan; E.J. Essien; S. Sansgiry

• Book ID: 119309165
• Publisher: John Wiley and Sons
• Year: 2011
• Tongue: English
• Weight: 57 KB
• Volume: 14
• Category: Article
• ISSN: 1098-3015
• DOI: 10.1016/j.jval.2011.02.384